+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Allogeneic Stem Cells - Global Strategic Business Report

  • PDF Icon

    Report

  • 89 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302352
The global market for Allogeneic Stem Cells was estimated at US$1.2 Billion in 2023 and is projected to reach US$2.4 Billion by 2030, growing at a CAGR of 10.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Allogeneic Stem Cells Market - Key Trends & Drivers Summarized

What Are Allogeneic Stem Cells, And Why Are They Pivotal In Modern Medicine?

Allogeneic stem cells are stem cells derived from a donor, which are used to treat patients in need of stem cell therapies or regenerative treatments. Unlike autologous stem cells, which are harvested from the patient's own body, allogeneic stem cells come from a genetically similar but different individual, often a sibling or unrelated donor. These cells have the unique ability to replace or repair damaged cells and tissues, making them highly effective in treating a wide range of diseases, including blood cancers, immune disorders, and degenerative diseases. The use of allogeneic stem cells is particularly crucial in hematopoietic stem cell transplants (HSCT) for treating leukemia, lymphoma, and other life-threatening conditions where the patient's own cells are either defective or destroyed by disease or treatments like chemotherapy.

Allogeneic stem cells hold significant potential due to their ability to provide a readily available source of stem cells, especially in situations where time is critical, such as treating aggressive cancers. Furthermore, these cells are used for patients who cannot use their own stem cells due to underlying genetic disorders or damaged bone marrow. The promise of allogeneic stem cells extends beyond oncology, as ongoing research is exploring their applications in treating autoimmune diseases, cardiovascular diseases, and even spinal cord injuries. As modern medicine increasingly relies on regenerative therapies and personalized treatments, allogeneic stem cell therapy is playing a pivotal role in transforming the way critical illnesses are managed and cured.

What Types Of Allogeneic Stem Cells Are Available, And How Do They Serve Different Medical Purposes?

Allogeneic stem cells are categorized based on their origin, each type serving different medical purposes based on their unique properties. Hematopoietic stem cells (HSCs), derived from bone marrow, peripheral blood, or umbilical cord blood, are the most commonly used type in clinical settings. HSCs have the remarkable ability to differentiate into various blood cells, making them essential in treating hematological disorders such as leukemia, lymphoma, and aplastic anemia.

Bone marrow transplants, a type of allogeneic stem cell therapy, rely on HSCs to restore the patient's blood and immune system, replacing the diseased or damaged cells with healthy donor cells. Cord blood, in particular, is emerging as a valuable source of HSCs because it is readily available, rich in stem cells, and poses fewer risks of graft-versus-host disease (GVHD) compared to other sources.

In addition to hematopoietic stem cells, mesenchymal stem cells (MSCs) are another type of allogeneic stem cell gaining popularity in the field of regenerative medicine. MSCs, typically sourced from the bone marrow, adipose tissue, or umbilical cord tissue, have the ability to differentiate into bone, cartilage, and muscle cells. These cells are widely researched for their potential to repair damaged tissues, making them valuable in treating conditions such as osteoarthritis, heart disease, and spinal cord injuries.

Moreover, MSCs have immunomodulatory properties, meaning they can regulate immune responses, which is crucial for treating autoimmune diseases and reducing inflammation. By offering a diverse range of therapeutic applications, allogeneic stem cells are unlocking new possibilities in the treatment of both acute and chronic conditions, driving innovation in fields such as orthopedics, neurology, and cardiology.

How Are Technological Advancements Impacting The Allogeneic Stem Cells Market?

Technological advancements are significantly enhancing the capabilities and reach of allogeneic stem cell therapies, driving innovation in both their development and clinical application. One of the most transformative advancements is the improvement in cell expansion and cryopreservation technologies. Cell expansion enables the cultivation of large quantities of stem cells from a single donor, ensuring a consistent supply of viable cells for therapeutic use.

This is particularly important in cases where patients require multiple treatments or when stem cells need to be stored for future use. Cryopreservation techniques have also evolved, allowing for the long-term storage of allogeneic stem cells without compromising their viability or efficacy. This advancement is crucial for creating stem cell banks, where matched donor cells can be readily available for patients who need urgent transplants.

Additionally, advancements in genetic engineering, particularly in the development of gene-edited allogeneic stem cells, are revolutionizing the field. CRISPR and other gene-editing tools are being used to modify donor stem cells to reduce the risk of immune rejection and graft-versus-host disease (GVHD), one of the major challenges in allogeneic transplants. By modifying the cells to make them more compatible with the recipient's immune system, researchers are improving the safety and success rates of these treatments.

Furthermore, breakthroughs in immune tolerance protocols and personalized medicine are allowing for more precise matching of donor cells to patients, improving outcomes and reducing complications. As research continues, technological advancements are poised to further expand the potential of allogeneic stem cells, making therapies more accessible, effective, and tailored to individual patient needs.

What Is Driving The Growth In The Allogeneic Stem Cells Market?

The growth in the allogeneic stem cells market is driven by several key factors, largely influenced by advancements in medical research, rising incidence of chronic diseases, and increasing demand for regenerative therapies. One of the primary growth drivers is the expanding use of allogeneic stem cell transplants in the treatment of cancers, particularly blood cancers such as leukemia and lymphoma.

As the global incidence of these diseases continues to rise, so does the demand for effective treatment options like hematopoietic stem cell transplants (HSCT), which rely on allogeneic stem cells to replace diseased blood cells and regenerate the immune system. This demand is further supported by the growing number of registered stem cell donors and cord blood banks, ensuring a broader pool of potential donors for patients in need of life-saving treatments.

Another significant driver is the increasing research and development in regenerative medicine, where allogeneic stem cells are playing an essential role. Allogeneic mesenchymal stem cells (MSCs), in particular, are gaining attention for their potential in treating a wide range of conditions beyond oncology, including autoimmune diseases, cardiovascular disorders, and orthopedic injuries. The ability of these stem cells to modulate immune responses and regenerate damaged tissues makes them highly sought after in developing new therapies for chronic and degenerative diseases.

Additionally, the shift toward personalized medicine is boosting the adoption of allogeneic stem cell therapies, as advancements in cell matching and genetic profiling enable more precise and effective treatments. The ongoing development of innovative delivery systems and reduced treatment costs are also making these therapies more accessible, contributing to the rapid expansion of the allogeneic stem cell market. As healthcare systems worldwide continue to prioritize advanced therapies that offer long-term health benefits, the allogeneic stem cells market is poised for robust growth.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Regenerative Therapy Application segment, which is expected to reach US$1.6 Billion by 2030 with a CAGR of a 11.8%. The Drug Discovery & Development Application segment is also set to grow at 9.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $304.2 Million in 2023, and China, forecasted to grow at an impressive 14.5% CAGR to reach $572.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Allogeneic Stem Cells Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Allogeneic Stem Cells Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Allogeneic Stem Cells Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Allogeneic Stem Cells Market such as Biosolution Co. Ltd., Cynata Therapeutics Ltd., JCR Pharmaceuticals Co. Ltd., Lineage Cell Therapeutics Inc., MEDIPOST Co. Ltd. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 33 companies featured in this Global Allogeneic Stem Cells market report include:

  • Biosolution Co. Ltd.
  • Cynata Therapeutics Ltd.
  • JCR Pharmaceuticals Co. Ltd.
  • Lineage Cell Therapeutics Inc.
  • MEDIPOST Co. Ltd.
  • MiMedx Group Inc.
  • Osiris Therapeutics Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Allogeneic Stem Cells - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Advanced Regenerative Medicine Drives Growth of Allogeneic Stem Cells Market
  • Increased Adoption of Allogeneic Stem Cells in Cancer and Immunotherapy Expands Addressable Market
  • Surge in Demand for Allogeneic Stem Cells for Wound Healing and Tissue Regeneration Fuels Market Growth
  • Growing Focus on Allogeneic Stem Cells for Treating Autoimmune Diseases Strengthens Business Case
  • Rising Adoption of Allogeneic Stem Cells in Bone Marrow Transplants and Hematologic Disorders Sets the Stage for Market Growth
  • Surge in Use of Allogeneic Stem Cells in Cardiovascular and Neurological Therapies Expands Market Opportunities
  • Growing Demand for Allogeneic Stem Cells in Organ and Tissue Transplants Expands Addressable Market
  • Rising Focus on Allogeneic Stem Cells for Orthopedic and Musculoskeletal Regeneration Fuels Market Demand
  • Growing Use of Allogeneic Stem Cells in Anti-Aging and Cosmetic Applications Strengthens Business Case
  • Rising Use of Allogeneic Stem Cells in Diabetes and Metabolic Disease Treatments Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Regenerative Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Regenerative Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Regenerative Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Allogeneic Stem Cells Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 11: USA Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 12: USA Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 13: USA 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
CANADA
  • Table 14: Canada Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 15: Canada Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 16: Canada 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
JAPAN
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 17: Japan Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 18: Japan Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: Japan 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
CHINA
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 20: China Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 21: China Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: China 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
EUROPE
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 23: Europe Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 24: Europe Historic Review for Allogeneic Stem Cells by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: Europe 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 26: Europe Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 27: Europe Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: Europe 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
FRANCE
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 29: France Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 30: France Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: France 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
GERMANY
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 32: Germany Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: Germany Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: Germany 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
ITALY
  • Table 35: Italy Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: Italy Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: Italy 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 38: UK Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: UK Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 40: UK 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
SPAIN
  • Table 41: Spain Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 42: Spain Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 43: Spain 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
RUSSIA
  • Table 44: Russia Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Russia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 46: Russia 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 47: Rest of Europe Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 48: Rest of Europe Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 49: Rest of Europe 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 50: Asia-Pacific Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 51: Asia-Pacific Historic Review for Allogeneic Stem Cells by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 52: Asia-Pacific 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 54: Asia-Pacific Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 55: Asia-Pacific 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
AUSTRALIA
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • Table 56: Australia Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: Australia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 58: Australia 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
INDIA
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • Table 59: India Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 60: India Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 61: India 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
SOUTH KOREA
  • Table 62: South Korea Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: South Korea Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 64: South Korea 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
  • Table 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 66: Rest of Asia-Pacific Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 67: Rest of Asia-Pacific 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
LATIN AMERICA
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • Table 68: Latin America Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 69: Latin America Historic Review for Allogeneic Stem Cells by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 70: Latin America 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • Table 71: Latin America Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 72: Latin America Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 73: Latin America 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
ARGENTINA
  • Table 74: Argentina Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 75: Argentina Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 76: Argentina 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
BRAZIL
  • Table 77: Brazil Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 78: Brazil Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 79: Brazil 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
MEXICO
  • Table 80: Mexico Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 81: Mexico Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 82: Mexico 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
  • Table 83: Rest of Latin America Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 84: Rest of Latin America Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 85: Rest of Latin America 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
MIDDLE EAST
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • Table 86: Middle East Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 87: Middle East Historic Review for Allogeneic Stem Cells by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 88: Middle East 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • Table 89: Middle East Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 90: Middle East Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 91: Middle East 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
IRAN
  • Table 92: Iran Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 93: Iran Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 94: Iran 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
ISRAEL
  • Table 95: Israel Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 96: Israel Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 97: Israel 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
SAUDI ARABIA
  • Table 98: Saudi Arabia Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 99: Saudi Arabia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 100: Saudi Arabia 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
  • Table 101: UAE Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 102: UAE Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 103: UAE 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
  • Table 104: Rest of Middle East Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 105: Rest of Middle East Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 106: Rest of Middle East 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
AFRICA
  • Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • Table 107: Africa Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 108: Africa Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 109: Africa 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned

Some of the 33 companies featured in this Global Allogeneic Stem Cells market report include:
  • Biosolution Co. Ltd.
  • Cynata Therapeutics Ltd.
  • JCR Pharmaceuticals Co. Ltd.
  • Lineage Cell Therapeutics Inc.
  • MEDIPOST Co. Ltd.
  • MiMedx Group Inc.
  • Osiris Therapeutics Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.

Table Information